ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SHOX
|
ENSG00000185960.8 | SHOX |
SHOX
|
ENSGR0000185960.8 | SHOX |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_151034734 | 2.52 |
ENST00000260843.4 |
GPR87 |
G protein-coupled receptor 87 |
chr12_-_28123206 | 2.13 |
ENST00000542963.1 ENST00000535992.1 |
PTHLH |
parathyroid hormone-like hormone |
chr19_-_51522955 | 2.03 |
ENST00000358789.3 |
KLK10 |
kallikrein-related peptidase 10 |
chr12_-_52967600 | 1.94 |
ENST00000549343.1 ENST00000305620.2 |
KRT74 |
keratin 74 |
chr5_-_1882858 | 1.88 |
ENST00000511126.1 ENST00000231357.2 |
IRX4 |
iroquois homeobox 4 |
chr12_-_28122980 | 1.84 |
ENST00000395868.3 ENST00000534890.1 |
PTHLH |
parathyroid hormone-like hormone |
chr15_+_101420028 | 1.61 |
ENST00000557963.1 ENST00000346623.6 |
ALDH1A3 |
aldehyde dehydrogenase 1 family, member A3 |
chr12_-_89746173 | 1.12 |
ENST00000308385.6 |
DUSP6 |
dual specificity phosphatase 6 |
chr17_+_47448102 | 1.05 |
ENST00000576461.1 |
RP11-81K2.1 |
Uncharacterized protein |
chr7_+_115862858 | 1.01 |
ENST00000393481.2 |
TES |
testis derived transcript (3 LIM domains) |
chr13_-_46716969 | 0.94 |
ENST00000435666.2 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
chrX_+_105937068 | 0.92 |
ENST00000324342.3 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
chr2_+_68961934 | 0.84 |
ENST00000409202.3 |
ARHGAP25 |
Rho GTPase activating protein 25 |
chr12_+_4385230 | 0.83 |
ENST00000536537.1 |
CCND2 |
cyclin D2 |
chr2_+_68961905 | 0.81 |
ENST00000295381.3 |
ARHGAP25 |
Rho GTPase activating protein 25 |
chr12_-_28125638 | 0.81 |
ENST00000545234.1 |
PTHLH |
parathyroid hormone-like hormone |
chr19_-_51523412 | 0.76 |
ENST00000391805.1 ENST00000599077.1 |
KLK10 |
kallikrein-related peptidase 10 |
chr17_-_39191107 | 0.74 |
ENST00000344363.5 |
KRTAP1-3 |
keratin associated protein 1-3 |
chr3_+_141106643 | 0.74 |
ENST00000514251.1 |
ZBTB38 |
zinc finger and BTB domain containing 38 |
chr19_-_51523275 | 0.73 |
ENST00000309958.3 |
KLK10 |
kallikrein-related peptidase 10 |
chr16_+_12059050 | 0.73 |
ENST00000396495.3 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr4_-_41884620 | 0.71 |
ENST00000504870.1 |
LINC00682 |
long intergenic non-protein coding RNA 682 |
chr3_-_79816965 | 0.71 |
ENST00000464233.1 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr6_-_32908792 | 0.70 |
ENST00000418107.2 |
HLA-DMB |
major histocompatibility complex, class II, DM beta |
chr17_-_64225508 | 0.70 |
ENST00000205948.6 |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
chr17_+_72427477 | 0.66 |
ENST00000342648.5 ENST00000481232.1 |
GPRC5C |
G protein-coupled receptor, family C, group 5, member C |
chr4_-_116034979 | 0.66 |
ENST00000264363.2 |
NDST4 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 |
chr12_-_10282742 | 0.65 |
ENST00000298523.5 ENST00000396484.2 ENST00000310002.4 |
CLEC7A |
C-type lectin domain family 7, member A |
chr1_-_92952433 | 0.65 |
ENST00000294702.5 |
GFI1 |
growth factor independent 1 transcription repressor |
chr7_-_22234381 | 0.65 |
ENST00000458533.1 |
RAPGEF5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
chr11_-_129062093 | 0.64 |
ENST00000310343.9 |
ARHGAP32 |
Rho GTPase activating protein 32 |
chr8_+_101170563 | 0.64 |
ENST00000520508.1 ENST00000388798.2 |
SPAG1 |
sperm associated antigen 1 |
chrX_+_43515467 | 0.64 |
ENST00000338702.3 ENST00000542639.1 |
MAOA |
monoamine oxidase A |
chr6_-_41039567 | 0.62 |
ENST00000468811.1 |
OARD1 |
O-acyl-ADP-ribose deacylase 1 |
chr7_-_25268104 | 0.62 |
ENST00000222674.2 |
NPVF |
neuropeptide VF precursor |
chr16_+_12059091 | 0.61 |
ENST00000562385.1 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr15_-_55562479 | 0.60 |
ENST00000564609.1 |
RAB27A |
RAB27A, member RAS oncogene family |
chr2_-_216946500 | 0.58 |
ENST00000265322.7 |
PECR |
peroxisomal trans-2-enoyl-CoA reductase |
chrX_-_110655306 | 0.58 |
ENST00000371993.2 |
DCX |
doublecortin |
chr5_-_24645078 | 0.57 |
ENST00000264463.4 |
CDH10 |
cadherin 10, type 2 (T2-cadherin) |
chr7_+_138145076 | 0.56 |
ENST00000343526.4 |
TRIM24 |
tripartite motif containing 24 |
chr12_+_28410128 | 0.54 |
ENST00000381259.1 ENST00000381256.1 |
CCDC91 |
coiled-coil domain containing 91 |
chr6_-_111927062 | 0.54 |
ENST00000359831.4 |
TRAF3IP2 |
TRAF3 interacting protein 2 |
chr16_-_29910853 | 0.53 |
ENST00000308713.5 |
SEZ6L2 |
seizure related 6 homolog (mouse)-like 2 |
chr17_-_27418537 | 0.53 |
ENST00000408971.2 |
TIAF1 |
TGFB1-induced anti-apoptotic factor 1 |
chr12_+_19358228 | 0.53 |
ENST00000424268.1 ENST00000543806.1 |
PLEKHA5 |
pleckstrin homology domain containing, family A member 5 |
chr15_+_75080883 | 0.53 |
ENST00000567571.1 |
CSK |
c-src tyrosine kinase |
chr2_+_143635067 | 0.53 |
ENST00000264170.4 |
KYNU |
kynureninase |
chr3_+_111718173 | 0.52 |
ENST00000494932.1 |
TAGLN3 |
transgelin 3 |
chr2_-_61697862 | 0.52 |
ENST00000398571.2 |
USP34 |
ubiquitin specific peptidase 34 |
chr7_+_116660246 | 0.52 |
ENST00000434836.1 ENST00000393443.1 ENST00000465133.1 ENST00000477742.1 ENST00000393447.4 ENST00000393444.3 |
ST7 |
suppression of tumorigenicity 7 |
chr9_+_2159850 | 0.52 |
ENST00000416751.1 |
SMARCA2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr6_-_39693111 | 0.52 |
ENST00000373215.3 ENST00000538893.1 ENST00000287152.7 ENST00000373216.3 |
KIF6 |
kinesin family member 6 |
chr13_-_95131923 | 0.50 |
ENST00000377028.5 ENST00000446125.1 |
DCT |
dopachrome tautomerase |
chr8_-_42234745 | 0.49 |
ENST00000220812.2 |
DKK4 |
dickkopf WNT signaling pathway inhibitor 4 |
chr14_-_38064198 | 0.48 |
ENST00000250448.2 |
FOXA1 |
forkhead box A1 |
chr4_-_105416039 | 0.47 |
ENST00000394767.2 |
CXXC4 |
CXXC finger protein 4 |
chr3_-_52090461 | 0.47 |
ENST00000296483.6 ENST00000495880.1 |
DUSP7 |
dual specificity phosphatase 7 |
chr3_+_111718036 | 0.46 |
ENST00000455401.2 |
TAGLN3 |
transgelin 3 |
chr6_-_87804815 | 0.46 |
ENST00000369582.2 |
CGA |
glycoprotein hormones, alpha polypeptide |
chr3_-_157824292 | 0.46 |
ENST00000483851.2 |
SHOX2 |
short stature homeobox 2 |
chr15_+_93443419 | 0.45 |
ENST00000557381.1 ENST00000420239.2 |
CHD2 |
chromodomain helicase DNA binding protein 2 |
chr15_-_55563072 | 0.45 |
ENST00000567380.1 ENST00000565972.1 ENST00000569493.1 |
RAB27A |
RAB27A, member RAS oncogene family |
chr13_+_78109884 | 0.44 |
ENST00000377246.3 ENST00000349847.3 |
SCEL |
sciellin |
chr13_+_78109804 | 0.44 |
ENST00000535157.1 |
SCEL |
sciellin |
chr18_+_57567180 | 0.44 |
ENST00000316660.6 ENST00000269518.9 |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
chr1_+_214161272 | 0.44 |
ENST00000498508.2 ENST00000366958.4 |
PROX1 |
prospero homeobox 1 |
chr9_-_123812542 | 0.43 |
ENST00000223642.1 |
C5 |
complement component 5 |
chr1_+_214161854 | 0.42 |
ENST00000435016.1 |
PROX1 |
prospero homeobox 1 |
chr12_-_52828147 | 0.42 |
ENST00000252245.5 |
KRT75 |
keratin 75 |
chr3_+_111717600 | 0.41 |
ENST00000273368.4 |
TAGLN3 |
transgelin 3 |
chr12_-_10282836 | 0.40 |
ENST00000304084.8 ENST00000353231.5 ENST00000525605.1 |
CLEC7A |
C-type lectin domain family 7, member A |
chr12_-_31479045 | 0.40 |
ENST00000539409.1 ENST00000395766.1 |
FAM60A |
family with sequence similarity 60, member A |
chr20_+_30697298 | 0.39 |
ENST00000398022.2 |
TM9SF4 |
transmembrane 9 superfamily protein member 4 |
chr13_-_41593425 | 0.39 |
ENST00000239882.3 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
chr8_+_105235572 | 0.39 |
ENST00000523362.1 |
RIMS2 |
regulating synaptic membrane exocytosis 2 |
chr3_+_121774202 | 0.39 |
ENST00000469710.1 ENST00000493101.1 ENST00000330540.2 ENST00000264468.5 |
CD86 |
CD86 molecule |
chr1_+_153747746 | 0.39 |
ENST00000368661.3 |
SLC27A3 |
solute carrier family 27 (fatty acid transporter), member 3 |
chrX_-_71458802 | 0.37 |
ENST00000373657.1 ENST00000334463.3 |
ERCC6L |
excision repair cross-complementing rodent repair deficiency, complementation group 6-like |
chr7_-_87342564 | 0.36 |
ENST00000265724.3 ENST00000416177.1 |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
chr7_-_22233442 | 0.36 |
ENST00000401957.2 |
RAPGEF5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
chr18_-_33709268 | 0.36 |
ENST00000269187.5 ENST00000590986.1 ENST00000440549.2 |
SLC39A6 |
solute carrier family 39 (zinc transporter), member 6 |
chr6_+_31895254 | 0.36 |
ENST00000299367.5 ENST00000442278.2 |
C2 |
complement component 2 |
chr11_-_117747327 | 0.35 |
ENST00000584230.1 ENST00000527429.1 ENST00000584394.1 ENST00000532984.1 |
FXYD6 FXYD6-FXYD2 |
FXYD domain containing ion transport regulator 6 FXYD6-FXYD2 readthrough |
chr4_-_143227088 | 0.33 |
ENST00000511838.1 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr2_-_166930131 | 0.32 |
ENST00000303395.4 ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A |
sodium channel, voltage-gated, type I, alpha subunit |
chr12_-_14133053 | 0.32 |
ENST00000609686.1 |
GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
chr1_+_50569575 | 0.32 |
ENST00000371827.1 |
ELAVL4 |
ELAV like neuron-specific RNA binding protein 4 |
chr20_-_21494654 | 0.32 |
ENST00000377142.4 |
NKX2-2 |
NK2 homeobox 2 |
chr14_+_72052983 | 0.31 |
ENST00000358550.2 |
SIPA1L1 |
signal-induced proliferation-associated 1 like 1 |
chr3_+_111717511 | 0.31 |
ENST00000478951.1 ENST00000393917.2 |
TAGLN3 |
transgelin 3 |
chrX_+_68835911 | 0.31 |
ENST00000525810.1 ENST00000527388.1 ENST00000374553.2 ENST00000374552.4 ENST00000338901.3 ENST00000524573.1 |
EDA |
ectodysplasin A |
chr1_+_167298281 | 0.31 |
ENST00000367862.5 |
POU2F1 |
POU class 2 homeobox 1 |
chr4_-_57547870 | 0.31 |
ENST00000381260.3 ENST00000420433.1 ENST00000554144.1 ENST00000557328.1 |
HOPX |
HOP homeobox |
chr1_+_180601139 | 0.31 |
ENST00000367590.4 ENST00000367589.3 |
XPR1 |
xenotropic and polytropic retrovirus receptor 1 |
chr15_-_37393406 | 0.30 |
ENST00000338564.5 ENST00000558313.1 ENST00000340545.5 |
MEIS2 |
Meis homeobox 2 |
chr13_-_28545276 | 0.30 |
ENST00000381020.7 |
CDX2 |
caudal type homeobox 2 |
chr12_-_53994805 | 0.30 |
ENST00000328463.7 |
ATF7 |
activating transcription factor 7 |
chr8_-_102803163 | 0.29 |
ENST00000523645.1 ENST00000520346.1 ENST00000220931.6 ENST00000522448.1 ENST00000522951.1 ENST00000522252.1 ENST00000519098.1 |
NCALD |
neurocalcin delta |
chr5_+_66300446 | 0.29 |
ENST00000261569.7 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
chr14_+_21156915 | 0.29 |
ENST00000397990.4 ENST00000555597.1 |
ANG RNASE4 |
angiogenin, ribonuclease, RNase A family, 5 ribonuclease, RNase A family, 4 |
chr9_-_69229650 | 0.29 |
ENST00000416428.1 |
CBWD6 |
COBW domain containing 6 |
chr1_+_74701062 | 0.28 |
ENST00000326637.3 |
TNNI3K |
TNNI3 interacting kinase |
chr4_-_57547454 | 0.28 |
ENST00000556376.2 |
HOPX |
HOP homeobox |
chr18_-_3219847 | 0.27 |
ENST00000261606.7 |
MYOM1 |
myomesin 1 |
chr12_+_41831485 | 0.27 |
ENST00000539469.2 ENST00000298919.7 |
PDZRN4 |
PDZ domain containing ring finger 4 |
chr19_+_48949030 | 0.27 |
ENST00000253237.5 |
GRWD1 |
glutamate-rich WD repeat containing 1 |
chr2_-_74619152 | 0.26 |
ENST00000440727.1 ENST00000409240.1 |
DCTN1 |
dynactin 1 |
chr15_+_58702742 | 0.26 |
ENST00000356113.6 ENST00000414170.3 |
LIPC |
lipase, hepatic |
chr18_+_59000815 | 0.26 |
ENST00000262717.4 |
CDH20 |
cadherin 20, type 2 |
chr6_-_32157947 | 0.26 |
ENST00000375050.4 |
PBX2 |
pre-B-cell leukemia homeobox 2 |
chr15_-_55562582 | 0.26 |
ENST00000396307.2 |
RAB27A |
RAB27A, member RAS oncogene family |
chr4_+_69313145 | 0.25 |
ENST00000305363.4 |
TMPRSS11E |
transmembrane protease, serine 11E |
chr2_-_50201327 | 0.25 |
ENST00000412315.1 |
NRXN1 |
neurexin 1 |
chr3_-_57233966 | 0.25 |
ENST00000473921.1 ENST00000295934.3 |
HESX1 |
HESX homeobox 1 |
chr6_+_153552455 | 0.25 |
ENST00000392385.2 |
AL590867.1 |
Uncharacterized protein; cDNA FLJ59044, highly similar to LINE-1 reverse transcriptase homolog |
chr2_-_74618964 | 0.25 |
ENST00000417090.1 ENST00000409868.1 |
DCTN1 |
dynactin 1 |
chr5_+_59783540 | 0.24 |
ENST00000515734.2 |
PART1 |
prostate androgen-regulated transcript 1 (non-protein coding) |
chr3_+_130569429 | 0.24 |
ENST00000505330.1 ENST00000504381.1 ENST00000507488.2 ENST00000393221.4 |
ATP2C1 |
ATPase, Ca++ transporting, type 2C, member 1 |
chr1_+_68150744 | 0.24 |
ENST00000370986.4 ENST00000370985.3 |
GADD45A |
growth arrest and DNA-damage-inducible, alpha |
chr2_+_234826016 | 0.24 |
ENST00000324695.4 ENST00000433712.2 |
TRPM8 |
transient receptor potential cation channel, subfamily M, member 8 |
chr1_-_45956800 | 0.24 |
ENST00000538496.1 |
TESK2 |
testis-specific kinase 2 |
chr2_+_162272605 | 0.24 |
ENST00000389554.3 |
TBR1 |
T-box, brain, 1 |
chr20_+_42136308 | 0.24 |
ENST00000434666.1 ENST00000427442.2 ENST00000439769.1 ENST00000418998.1 |
L3MBTL1 |
l(3)mbt-like 1 (Drosophila) |
chr6_-_136788001 | 0.24 |
ENST00000544465.1 |
MAP7 |
microtubule-associated protein 7 |
chr7_-_44580861 | 0.24 |
ENST00000546276.1 ENST00000289547.4 ENST00000381160.3 ENST00000423141.1 |
NPC1L1 |
NPC1-like 1 |
chr12_-_86650077 | 0.23 |
ENST00000552808.2 ENST00000547225.1 |
MGAT4C |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr14_-_64194745 | 0.23 |
ENST00000247225.6 |
SGPP1 |
sphingosine-1-phosphate phosphatase 1 |
chr12_-_86650045 | 0.22 |
ENST00000604798.1 |
MGAT4C |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr2_-_136678123 | 0.22 |
ENST00000422708.1 |
DARS |
aspartyl-tRNA synthetase |
chr7_-_14026063 | 0.22 |
ENST00000443608.1 ENST00000438956.1 |
ETV1 |
ets variant 1 |
chrX_+_107288197 | 0.22 |
ENST00000415430.3 |
VSIG1 |
V-set and immunoglobulin domain containing 1 |
chr7_-_23510086 | 0.22 |
ENST00000258729.3 |
IGF2BP3 |
insulin-like growth factor 2 mRNA binding protein 3 |
chr6_-_22297730 | 0.22 |
ENST00000306482.1 |
PRL |
prolactin |
chr5_+_179159813 | 0.21 |
ENST00000292599.3 |
MAML1 |
mastermind-like 1 (Drosophila) |
chr8_-_20040601 | 0.21 |
ENST00000265808.7 ENST00000522513.1 |
SLC18A1 |
solute carrier family 18 (vesicular monoamine transporter), member 1 |
chr1_-_150738261 | 0.21 |
ENST00000448301.2 ENST00000368985.3 |
CTSS |
cathepsin S |
chr8_+_107738240 | 0.21 |
ENST00000449762.2 ENST00000297447.6 |
OXR1 |
oxidation resistance 1 |
chr8_-_20040638 | 0.21 |
ENST00000519026.1 ENST00000276373.5 ENST00000440926.1 ENST00000437980.1 |
SLC18A1 |
solute carrier family 18 (vesicular monoamine transporter), member 1 |
chr14_-_51027838 | 0.21 |
ENST00000555216.1 |
MAP4K5 |
mitogen-activated protein kinase kinase kinase kinase 5 |
chr10_+_119301928 | 0.21 |
ENST00000553456.3 |
EMX2 |
empty spiracles homeobox 2 |
chr4_+_114214125 | 0.20 |
ENST00000509550.1 |
ANK2 |
ankyrin 2, neuronal |
chrX_-_20236970 | 0.20 |
ENST00000379548.4 |
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
chr1_-_45956822 | 0.20 |
ENST00000372086.3 ENST00000341771.6 |
TESK2 |
testis-specific kinase 2 |
chr3_-_113897545 | 0.20 |
ENST00000467632.1 |
DRD3 |
dopamine receptor D3 |
chr11_-_69633792 | 0.20 |
ENST00000334134.2 |
FGF3 |
fibroblast growth factor 3 |
chr18_+_32173276 | 0.19 |
ENST00000591816.1 ENST00000588125.1 ENST00000598334.1 ENST00000588684.1 ENST00000554864.3 ENST00000399121.5 ENST00000595022.1 ENST00000269190.7 ENST00000399097.3 |
DTNA |
dystrobrevin, alpha |
chr10_+_102222798 | 0.19 |
ENST00000343737.5 |
WNT8B |
wingless-type MMTV integration site family, member 8B |
chr1_+_153746683 | 0.19 |
ENST00000271857.2 |
SLC27A3 |
solute carrier family 27 (fatty acid transporter), member 3 |
chr17_-_48785216 | 0.19 |
ENST00000285243.6 |
ANKRD40 |
ankyrin repeat domain 40 |
chr4_+_88571429 | 0.19 |
ENST00000339673.6 ENST00000282479.7 |
DMP1 |
dentin matrix acidic phosphoprotein 1 |
chr16_-_4852915 | 0.18 |
ENST00000322048.7 |
ROGDI |
rogdi homolog (Drosophila) |
chr5_+_59783941 | 0.18 |
ENST00000506884.1 ENST00000504876.2 |
PART1 |
prostate androgen-regulated transcript 1 (non-protein coding) |
chr7_+_129015484 | 0.18 |
ENST00000490911.1 |
AHCYL2 |
adenosylhomocysteinase-like 2 |
chrX_+_107288239 | 0.18 |
ENST00000217957.5 |
VSIG1 |
V-set and immunoglobulin domain containing 1 |
chr17_+_39411636 | 0.18 |
ENST00000394008.1 |
KRTAP9-9 |
keratin associated protein 9-9 |
chr2_+_45168875 | 0.18 |
ENST00000260653.3 |
SIX3 |
SIX homeobox 3 |
chr4_-_170897045 | 0.18 |
ENST00000508313.1 |
RP11-205M3.3 |
RP11-205M3.3 |
chr14_-_36988882 | 0.17 |
ENST00000498187.2 |
NKX2-1 |
NK2 homeobox 1 |
chr20_+_56964253 | 0.17 |
ENST00000395802.3 |
VAPB |
VAMP (vesicle-associated membrane protein)-associated protein B and C |
chr1_+_62439037 | 0.17 |
ENST00000545929.1 |
INADL |
InaD-like (Drosophila) |
chr12_-_102591604 | 0.17 |
ENST00000329406.4 |
PMCH |
pro-melanin-concentrating hormone |
chr1_+_198608146 | 0.17 |
ENST00000367376.2 ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
chr6_+_135502501 | 0.17 |
ENST00000527615.1 ENST00000420123.2 ENST00000525369.1 ENST00000528774.1 ENST00000534121.1 ENST00000534044.1 ENST00000533624.1 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr21_-_42219065 | 0.17 |
ENST00000400454.1 |
DSCAM |
Down syndrome cell adhesion molecule |
chr18_-_31803435 | 0.17 |
ENST00000589544.1 ENST00000269185.4 ENST00000261592.5 |
NOL4 |
nucleolar protein 4 |
chr7_+_100136811 | 0.17 |
ENST00000300176.4 ENST00000262935.4 |
AGFG2 |
ArfGAP with FG repeats 2 |
chr9_+_470288 | 0.17 |
ENST00000382303.1 |
KANK1 |
KN motif and ankyrin repeat domains 1 |
chr2_-_176046391 | 0.17 |
ENST00000392541.3 ENST00000409194.1 |
ATP5G3 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) |
chr14_-_98444386 | 0.16 |
ENST00000556462.1 ENST00000556138.1 |
C14orf64 |
chromosome 14 open reading frame 64 |
chr1_+_209878182 | 0.16 |
ENST00000367027.3 |
HSD11B1 |
hydroxysteroid (11-beta) dehydrogenase 1 |
chr3_-_33686743 | 0.16 |
ENST00000333778.6 ENST00000539981.1 |
CLASP2 |
cytoplasmic linker associated protein 2 |
chr16_+_89334512 | 0.16 |
ENST00000602042.1 |
AC137932.1 |
AC137932.1 |
chr17_-_9929581 | 0.16 |
ENST00000437099.2 ENST00000396115.2 |
GAS7 |
growth arrest-specific 7 |
chr2_+_68962014 | 0.16 |
ENST00000467265.1 |
ARHGAP25 |
Rho GTPase activating protein 25 |
chr8_-_17533838 | 0.16 |
ENST00000400046.1 |
MTUS1 |
microtubule associated tumor suppressor 1 |
chr4_+_88754113 | 0.16 |
ENST00000560249.1 ENST00000540395.1 ENST00000511670.1 ENST00000361056.3 |
MEPE |
matrix extracellular phosphoglycoprotein |
chr19_-_53758094 | 0.16 |
ENST00000601828.1 ENST00000598513.1 ENST00000599012.1 ENST00000333952.4 ENST00000598806.1 |
ZNF677 |
zinc finger protein 677 |
chr6_+_31583761 | 0.15 |
ENST00000376049.4 |
AIF1 |
allograft inflammatory factor 1 |
chr4_+_78432907 | 0.15 |
ENST00000286758.4 |
CXCL13 |
chemokine (C-X-C motif) ligand 13 |
chr10_-_50970322 | 0.15 |
ENST00000374103.4 |
OGDHL |
oxoglutarate dehydrogenase-like |
chr14_+_32798547 | 0.15 |
ENST00000557354.1 ENST00000557102.1 ENST00000557272.1 |
AKAP6 |
A kinase (PRKA) anchor protein 6 |
chr6_-_111927449 | 0.15 |
ENST00000368761.5 ENST00000392556.4 ENST00000340026.6 |
TRAF3IP2 |
TRAF3 interacting protein 2 |
chr20_+_3776371 | 0.15 |
ENST00000245960.5 |
CDC25B |
cell division cycle 25B |
chr16_+_103816 | 0.15 |
ENST00000383018.3 ENST00000417493.1 |
SNRNP25 |
small nuclear ribonucleoprotein 25kDa (U11/U12) |
chr19_-_46088068 | 0.15 |
ENST00000263275.4 ENST00000323060.3 |
OPA3 |
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) |
chr4_-_39979576 | 0.15 |
ENST00000303538.8 ENST00000503396.1 |
PDS5A |
PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) |
chr2_+_171034646 | 0.15 |
ENST00000409044.3 ENST00000408978.4 |
MYO3B |
myosin IIIB |
chr7_+_154002189 | 0.14 |
ENST00000332007.3 |
DPP6 |
dipeptidyl-peptidase 6 |
chr9_-_5304432 | 0.14 |
ENST00000416837.1 ENST00000308420.3 |
RLN2 |
relaxin 2 |
chr5_+_69321074 | 0.14 |
ENST00000380751.5 ENST00000380750.3 ENST00000503931.1 ENST00000506542.1 |
SERF1B |
small EDRK-rich factor 1B (centromeric) |
chr8_+_94752349 | 0.14 |
ENST00000391680.1 |
RBM12B-AS1 |
RBM12B antisense RNA 1 |
chr2_-_30144432 | 0.14 |
ENST00000389048.3 |
ALK |
anaplastic lymphoma receptor tyrosine kinase |
chr17_-_40337470 | 0.14 |
ENST00000293330.1 |
HCRT |
hypocretin (orexin) neuropeptide precursor |
chr20_-_50722183 | 0.14 |
ENST00000371523.4 |
ZFP64 |
ZFP64 zinc finger protein |
chr11_+_75526212 | 0.14 |
ENST00000356136.3 |
UVRAG |
UV radiation resistance associated |
chr11_-_128894053 | 0.14 |
ENST00000392657.3 |
ARHGAP32 |
Rho GTPase activating protein 32 |
chr3_-_113897899 | 0.14 |
ENST00000383673.2 ENST00000295881.7 |
DRD3 |
dopamine receptor D3 |
chr12_-_91398796 | 0.14 |
ENST00000261172.3 ENST00000551767.1 |
EPYC |
epiphycan |
chr4_-_66536196 | 0.14 |
ENST00000511294.1 |
EPHA5 |
EPH receptor A5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 0.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 3.3 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.4 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.2 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 0.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.2 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.2 | GO:0043194 | voltage-gated sodium channel complex(GO:0001518) axon initial segment(GO:0043194) |
0.0 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0016013 | syntrophin complex(GO:0016013) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.8 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 4.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 1.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 1.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 0.9 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.3 | 1.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 0.7 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.7 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.2 | 1.3 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.2 | 0.6 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.2 | 0.5 | GO:0097052 | tryptophan catabolic process to acetyl-CoA(GO:0019442) L-kynurenine metabolic process(GO:0097052) |
0.2 | 4.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.3 | GO:0021778 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 0.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.4 | GO:0032641 | negative regulation of tolerance induction(GO:0002644) lymphotoxin A production(GO:0032641) interleukin-4 biosynthetic process(GO:0042097) lymphotoxin A biosynthetic process(GO:0042109) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 2.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.1 | 0.6 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.9 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.2 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.1 | 0.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.2 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 0.5 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.5 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 0.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.2 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.1 | 0.1 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.1 | 0.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.5 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.1 | 0.6 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.2 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.1 | 0.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 0.7 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.4 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.4 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.5 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.0 | 1.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 1.9 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.8 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.2 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.7 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.2 | GO:0048539 | immunoglobulin biosynthetic process(GO:0002378) bone marrow development(GO:0048539) |
0.0 | 0.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.1 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) establishment of meiotic spindle localization(GO:0051295) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 | 0.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 0.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.2 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.0 | 0.1 | GO:0002384 | hepatic immune response(GO:0002384) |
0.0 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.1 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.2 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.1 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.0 | 0.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) lead ion transport(GO:0015692) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0007568 | aging(GO:0007568) |
0.0 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.3 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.0 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.0 | 0.4 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
0.0 | 1.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.2 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.0 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.3 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.0 | 0.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:1902083 | cellular response to hydroperoxide(GO:0071447) negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.1 | GO:0007154 | cell communication(GO:0007154) |
0.0 | 1.5 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.0 | 0.0 | GO:0061743 | motor learning(GO:0061743) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.1 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.0 | 0.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.0 | 0.2 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 6.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 4.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 2.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 3.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 2.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 1.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 1.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 1.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.8 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 1.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 1.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 1.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 1.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 1.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 10.2 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.7 | 2.9 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.6 | 7.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 1.8 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.5 | 1.6 | GO:0051311 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
0.5 | 2.6 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
0.5 | 2.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 1.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.4 | 1.2 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.4 | 1.4 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.3 | 1.0 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.3 | 1.0 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.3 | 0.9 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.3 | 0.8 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.3 | 0.8 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.3 | 2.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.3 | 1.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 1.2 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.2 | 0.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 2.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 1.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 2.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.7 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.2 | 0.5 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.2 | 0.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 0.5 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) dGDP metabolic process(GO:0046066) |
0.1 | 0.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 1.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.1 | 0.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 1.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.8 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.4 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.1 | 1.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.6 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 1.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.6 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.1 | 0.8 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.5 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 1.2 | GO:0042262 | DNA protection(GO:0042262) |
0.1 | 0.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 1.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.5 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.1 | 0.1 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.1 | 0.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.5 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 15.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.3 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 2.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.7 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 3.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.3 | GO:1901253 | negative regulation of dendritic cell cytokine production(GO:0002731) negative regulation of intracellular transport of viral material(GO:1901253) |
0.1 | 0.3 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.1 | 1.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.4 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.1 | 0.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.4 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.1 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.4 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.1 | 1.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 1.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 0.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.3 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.2 | GO:0035377 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.1 | 0.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 1.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.2 | GO:1903487 | regulation of lactation(GO:1903487) |
0.1 | 0.1 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
0.1 | 0.2 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.1 | 0.5 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 5.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:0030910 | olfactory placode formation(GO:0030910) myotome development(GO:0061055) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 2.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.1 | 1.1 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.3 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 1.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 1.0 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.3 | GO:0072143 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.1 | GO:0070301 | response to hydrogen peroxide(GO:0042542) cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 2.7 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 0.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.1 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.1 | 1.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 2.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 2.8 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.3 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.0 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) negative regulation of Wnt protein secretion(GO:0061358) |
0.0 | 0.2 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.3 | GO:0006226 | dUMP biosynthetic process(GO:0006226) dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.0 | 0.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 1.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.4 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 1.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:1903179 | detoxification of mercury ion(GO:0050787) regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.0 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.0 | 0.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 1.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.0 | 1.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.0 | 0.1 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.0 | 0.2 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.2 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 1.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.0 | 0.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.0 | 0.1 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.8 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.0 | 0.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.0 | 0.8 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
0.0 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.2 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) telomere assembly(GO:0032202) |
0.0 | 0.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.2 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.2 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.0 | 0.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 1.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.5 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.6 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 1.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.7 | GO:0044247 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.2 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.0 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.8 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 1.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 1.5 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.2 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.5 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.3 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.0 | 0.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 0.0 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.1 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.0 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.6 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.2 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.8 | GO:1902403 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.3 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.0 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.2 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.2 | GO:0007507 | heart development(GO:0007507) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.0 | 0.2 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.3 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.0 | 0.4 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.0 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 1.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.7 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.2 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
0.0 | 0.1 | GO:0035855 | secretory granule organization(GO:0033363) megakaryocyte development(GO:0035855) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 4.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 1.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 2.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.9 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 1.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.5 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0032093 | SAM domain binding(GO:0032093) |
0.1 | 1.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.4 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.3 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.2 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.0 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 1.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.0 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 4.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.0 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 2.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 10.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.9 | 12.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.5 | 1.6 | GO:0005715 | late recombination nodule(GO:0005715) |
0.4 | 1.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.0 | GO:0018444 | translation release factor complex(GO:0018444) |
0.3 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 2.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 1.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 1.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 1.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 7.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 2.4 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 2.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 3.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 1.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.7 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.2 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.1 | 0.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.5 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.3 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.1 | 0.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 1.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.6 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 3.3 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.0 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.2 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.0 | 2.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.2 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.0 | 1.1 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 1.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 1.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0097449 | astrocyte projection(GO:0097449) growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.0 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.7 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0033150 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
0.0 | 1.7 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 1.5 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.3 | GO:0030175 | filopodium(GO:0030175) actin-based cell projection(GO:0098858) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.2 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.0 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.0 | 0.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.1 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.0 | 0.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.0 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.0 | 0.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 6.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.0 | 0.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.0 | 0.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 0.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 2.0 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 1.2 | GO:0005856 | cytoskeleton(GO:0005856) |
0.0 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.4 | 1.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.3 | 2.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 1.0 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.3 | 0.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.3 | 1.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.5 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
0.3 | 0.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 0.8 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.3 | 10.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 1.0 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 0.9 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.2 | 0.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 1.6 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 1.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 2.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 1.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.7 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.2 | 0.7 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 0.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 0.5 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.2 | 1.0 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 1.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.8 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.2 | 0.5 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 0.6 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.6 | GO:0015265 | glycerol channel activity(GO:0015254) urea channel activity(GO:0015265) |
0.1 | 0.4 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 7.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.6 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 1.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.4 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.1 | 0.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 2.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 8.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 3.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.4 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.4 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.3 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.1 | 1.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 1.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 2.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 0.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 0.4 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 0.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 1.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 1.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 4.2 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 1.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 2.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 8.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.2 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 2.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0035276 | aldehyde oxidase activity(GO:0004031) ethanol binding(GO:0035276) |
0.0 | 1.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 2.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 1.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.2 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
0.0 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.6 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.2 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.0 | 0.1 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.0 | 0.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.0 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 1.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.7 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.1 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 1.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.1 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.0 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.0 | 0.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.2 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.0 | 0.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.1 | GO:0019960 | C-X3-C chemokine receptor activity(GO:0016495) C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 1.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.2 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.0 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 1.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 1.0 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.0 | 0.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.0 | 0.1 | GO:0043142 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.0 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.0 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 1.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 2.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 1.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.0 | 0.1 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 5.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 2.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 2.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 2.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 1.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.9 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 2.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |